Cimzia Draws Even With Simponi at Six Months Post Launch According to Recent BioTrends Survey
New Market Research Report from BioTrends Provides Insight on How Rheumatologists are Utilizing Biologic Agents in the Treatment of Rheumatoid Arthritis
Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech’s New Psoriasis Agent Stelara (ustekinumab) is High
Reported Use Of AMAG’s Feraheme (ferumoxytol) Continues To Be Low, But A Number Of Nephrologists Are “On The Verge” Of Use
BioTrends Releases Three Publications -- TreatmentTrends® : US Nephrology, TreatmentTrends® : Renal Dietitians, and TreatmentTrends®: Anemia Managers –Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism
Page 8 of 17
